JP2025511184A5 - - Google Patents
Info
- Publication number
- JP2025511184A5 JP2025511184A5 JP2024558018A JP2024558018A JP2025511184A5 JP 2025511184 A5 JP2025511184 A5 JP 2025511184A5 JP 2024558018 A JP2024558018 A JP 2024558018A JP 2024558018 A JP2024558018 A JP 2024558018A JP 2025511184 A5 JP2025511184 A5 JP 2025511184A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- repressor
- item
- nucleic acid
- expression repressor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263325524P | 2022-03-30 | 2022-03-30 | |
| US63/325,524 | 2022-03-30 | ||
| US202263379849P | 2022-10-17 | 2022-10-17 | |
| US63/379,849 | 2022-10-17 | ||
| US202363478855P | 2023-01-06 | 2023-01-06 | |
| US63/478,855 | 2023-01-06 | ||
| PCT/US2023/065108 WO2023192911A2 (en) | 2022-03-30 | 2023-03-29 | Cxcl-modulating compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511184A JP2025511184A (ja) | 2025-04-15 |
| JP2025511184A5 true JP2025511184A5 (https=) | 2026-04-07 |
Family
ID=88203460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558018A Pending JP2025511184A (ja) | 2022-03-30 | 2023-03-29 | Ｃｘｃｌ調節組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250195625A1 (https=) |
| EP (1) | EP4499836A2 (https=) |
| JP (1) | JP2025511184A (https=) |
| CN (1) | CN119032172A (https=) |
| AU (1) | AU2023243459A1 (https=) |
| CA (1) | CA3255769A1 (https=) |
| TW (1) | TW202345871A (https=) |
| WO (1) | WO2023192911A2 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6444801B1 (en) * | 1996-11-15 | 2002-09-03 | Institute Of Cytosignal Research Inc. | Transcriptional inhibitor protein and the encoding DNA |
| EP2066335A4 (en) * | 2006-09-26 | 2010-01-20 | Univ Case Western Reserve | ZYTOKINSIGNALISIERUNG |
| HK1212628A1 (zh) * | 2012-06-27 | 2016-06-17 | 吉安特科技公司 | 用於抑制炎症的抗-cxcl9、抗-cxcl10、抗-cxcl11、抗-cxcl13、抗-cxcr3和抗-cxcr5试剂 |
| WO2018044940A1 (en) * | 2016-08-30 | 2018-03-08 | Beth Israel Deaconess Medical Center | Compositions and methods for treating a tumor suppressor deficient cancer |
-
2023
- 2023-03-29 US US18/852,300 patent/US20250195625A1/en active Pending
- 2023-03-29 CN CN202380031799.8A patent/CN119032172A/zh active Pending
- 2023-03-29 WO PCT/US2023/065108 patent/WO2023192911A2/en not_active Ceased
- 2023-03-29 EP EP23782038.6A patent/EP4499836A2/en active Pending
- 2023-03-29 AU AU2023243459A patent/AU2023243459A1/en active Pending
- 2023-03-29 TW TW112112099A patent/TW202345871A/zh unknown
- 2023-03-29 JP JP2024558018A patent/JP2025511184A/ja active Pending
- 2023-03-29 CA CA3255769A patent/CA3255769A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024501383A (ja) | エピジェネティック編集のための組成物および方法 | |
| Gray et al. | Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice | |
| JP2023543218A5 (https=) | ||
| Gopalan et al. | Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response | |
| JP2022527108A5 (https=) | ||
| JP2018505219A (ja) | エピゲノム編集のための組成物および方法 | |
| JP2005521393A5 (https=) | ||
| Ni et al. | EZH2 mediates miR‐146a‐5p/HIF‐1α to alleviate inflammation and glycolysis after acute spinal cord injury | |
| JP2023522020A5 (https=) | ||
| JP2023519518A5 (https=) | ||
| JP2010500291A5 (https=) | ||
| JP2023543056A5 (https=) | ||
| Ross et al. | Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression | |
| Roy Chowdhury et al. | KSHV genome harbors both constitutive and lytically induced enhancers | |
| JP2025511184A5 (https=) | ||
| CN115989321B (zh) | 病毒制剂、用于配制病毒制剂的溶液及其用途 | |
| CN118460655B (zh) | 抑制FXI基因表达的siRNA的制备方法 | |
| Ngai et al. | DNA methylation and histone modifications are the molecular lock in lentivirally transduced hematopoietic progenitor cells | |
| CN103045592B (zh) | 与流感病毒复制相关的长链非编码核酸片段以及它们的应用 | |
| JP2024028895A (ja) | オリゴヌクレオチド分子及び腫瘍治療におけるその応用 | |
| KR102839248B1 (ko) | Cas13 단백질 및 crRNA를 포함하는 코로나바이러스감염증-19 예방 또는 치료용 약학적 조성물 | |
| CN105907757A (zh) | Linc00052基因的用途及其相关药物 | |
| JP2025509242A5 (https=) | ||
| CN116724110A (zh) | 重组溶瘤病毒及其构建方法和用途 | |
| KR102238589B1 (ko) | 조류 인플루엔자 바이러스 감염 질환의 예방 또는 치료용 약학 조성물 |